Stock Research

Novo Nordisk gains 7% on Q1 beat: is it too late to buy NVO stock?

Novo Nordisk’s rebound got another lift on Wednesday after the Danish drugmaker delivered a first-quarter beat and showed that its new Wegovy pill is gaining traction faster than Wall Street...

CHECK STOCK PERFORMANCE

MARKET INFORMATION

  • LAST
    CHANGE
  • S&P 500
    7259.22
    +58.47 (+0.81)
  • DJI
    49298.25
    +356.34 (+0.73)
  • NASDAQ
    25326.13
    +258.33 (+1.03)
  • OIL
    28.42
    +0.27 (+0.96)

Today's Top Gainers

  • Stock
    Price Change
  • PHOE
    168.51%
  • SDOT
    91.19%
  • BLZE
    63.58%
  • SOBR
    63.53%
  • EVER
    63.04%
  • APUS
    59.57%
  • EZGO
    54.48%
  • SLQT
    52.43%
  • STRL
    52.22%
  • CIFG
    47.82%

Today's Top Losers

  • Stock
    Price Change
  • EMBC
    -57.84%
  • SKK
    -54.39%
  • WGS
    -49.20%
  • PMI
    -40.36%
  • BRBR
    -38.77%
  • UBXG
    -35.40%
  • FTCI
    -33.20%
  • CYAB
    -32.94%
  • PTIX
    -32.75%
  • HUBC
    -29.01%